Eli Lilly (LLY)
(Delayed Data from NYSE)
$918.52 USD
-2.97 (-0.32%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $919.03 +0.51 (0.06%) 5:00 PM ET
1-Strong Buy of 5 1
F Value F Growth D Momentum F VGM
Brokerage Reports
0 items in cart
Eli Lilly and Company [LLY]
Reports for Purchase
Showing records 141 - 160 ( 439 total )
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Key Takeaways From COVID-19 Vaccines and Antivirals Panels at Life Sciences Conference
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Eli Lilly and Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for LLY.
Provider: Stock Traders Daily
Analyst: Research Department